@medchemexpress.bsky.socialSeptember: #MuscularDystrophy Awareness Month
🔹DMD | PMO exon skipping; PPMOs & AOCs aim to improve muscle delivery
🔹DM1 | ASOs & AOCs target DMPK RNA
🔹OPMD | Gene therapy approaches are under exploration
🔹LGMD | Gene therapy & oligonucleotide approaches are being investigated for selected subtypes
@jdavismallory.bsky.socialNew episode of Between Pages and Screens is out today! Twenty Years Later: My Reunion by Ambulance. If you want the full episode, click on the link in the comments below! #Disability
#ChronicIllness
#MuscularDystrophy
#podcast
@jdavismallory.bsky.socialLessons From a 39-Year-Old Girl Living with Muscular Dystrophy. If you want the full essay, click on the link in the comments below! #disability #musculardystrophy #personalessay #chronicillness,
@stemcellnetwork.caSCN researchers are working to better understand #MuscleStemCells and develop treatments for #MuscularDystrophy and other muscle diseases. From restoring muscle stem cell function to developing anti-fibrotic treatments that reduce scarring and support #TissueRegeneration,
@pathfindersnma.bsky.socialOur next PAE Session is Wednesday 23rd September, 6pm-7pm.
The next session will be an open discussion.
Sign up to our sessions: https://ow.ly/H9CT50ZBo2a
#MuscularDystrophy #DisabilitySupport #PAEmployer #PathfindersNMA
@francesleckie.bsky.socialThis week's IL newsletter: Muscular Dystrophy UK is investing £1.5m in 10 new research projects, taking its current research commitment to more than £10m.
